tirzepatide depression and Risk | Mental Health Guide GLP-1 Depression Warning: Weight-Loss Drugs

Smolen JS, Aletaha D, McInnes IB

[26] [62] [63] Approximately 80% of those who use these stimulants see improvements in ADHD symptoms

This is consistent with weight-loss-mediated mechanisms accounting for most of the effect

Unlike earlier weight-loss medications, retatrutide is a triple receptor agonist , meaning it simultaneously activates three distinct hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors

Your provider can also guide you on how to combine the two safely assuming, of course, that weed is even legal in your state

Disclosure The authors declare no competing interests in this work